csirt@kutim:~/threat-intel/cve/CVE-2026-31764

Katalog CVE

CVSS 7.8 · High EPSS 0,17%

Kerentanan Improper Validation of Array Index pada linux kernel. Skor CVSS 3.1 7.8 (High) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: iio: imu: st_lsm6dsx: Set buffer sampling frequency for accelerometer only The st_lsm6dsx_hwfifo_odr_store() function, which is called when userspace writes the buffer sampling frequency sysfs attribute, calls st_lsm6dsx_check_odr(), which accesses the odr_table array at index `sensor->id`; since this array is only 2 entries long, an access for any sensor type other than accelerometer or gyroscope is an out-of-bounds access. The motivation for being able to set a buffer frequency different from the sensor sampling frequency is to support use cases that need accurate event detection (which requires a high sampling frequency) while retrieving sensor data at low frequency. Since all the supported event types are generated from acceleration data only, do not create the buffer sampling frequency attribute for sensor types other than the accelerometer.

Rincian

Terbit di NVD
1 Mei 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
7.8 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-129: Improper Validation of Array Index
EPSS (30 hari)
0,17% peluang dieksploitasi; lebih tinggi dari 5,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 6.19 hingga sebelum 6.19.12
linux linux kernel Versi 7.0 rc1
linux linux kernel Versi 7.0 rc2
linux linux kernel Versi 7.0 rc3
linux linux kernel Versi 7.0 rc4
linux linux kernel Versi 7.0 rc5
linux linux kernel Versi 7.0 rc6

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.